Express Pharma

AstraZeneca India collaborates with STEMI India

3

To emphasise the need to treat heart attacks within the ‘Golden Hour’

AstraZeneca Pharma India has announced a collaboration with STEMI India Charitable Trust, a ‘not for profit’ organisation founded by leading cardiologists Dr Thomas Alexander and Dr Ajit S Mullasari (STEMI India). Under the collaboration, STEMI India and AstraZeneca India will work together to emphasise the importance of the ‘Golden Hour’ and appropriate treatment strategies across the country for improving the standard of care for heart attack patients.

“ST elevation Myocardial Infarction (STEMI) is one of the most challenging clinical conditions in cardiology since a patient with STEMI requires coordinated action from multiple providers to deliver quick and appropriate care. The objective of STEMI India’s annual meet is provide fresh orientation to all caregivers on prompt treatment methods. Training experts are chosen from amongst recognized leaders in STEMI care from around the world,” said Dr Thomas Alexander, Founder, STEMI India.

Commenting on the partnership, Sanjay Murdeshwar, Managing Director, AstraZeneca India stated, “AstraZeneca India is pleased to partner with STEMI India. This partnership supports our commitment to drive a paradigm shift in the way Acute Coronary Syndrome (ACS) is managed in India through increased awareness of the STEMI India model for managing ACS patients and importance of pre-hospital management of STEMI patients.

Comments are closed.